Detalhe da pesquisa
1.
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.
Future Oncol
; 20(16): 1069-1077, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214149
2.
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer.
Oncologist
; 28(8): 691-698, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354528
3.
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Gastroenterology
; 160(4): 1359-1372.e13, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307028
4.
Sorafenib for Advanced and Refractory Desmoid Tumors.
N Engl J Med
; 379(25): 2417-2428, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575484
5.
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
J Natl Compr Canc Netw
; 19(1): 10-15, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406492
6.
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Lancet Oncol
; 21(4): 508-518, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135080
7.
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Cancer
; 126(13): 3021-3030, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320048
8.
A Phase Ib Study of Single-Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1604-e1613, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356383
9.
Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come.
Pancreatology
; 20(3): 391-393, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192904
10.
The economic burden of metastatic pancreatic cancer.
Pancreatology
; 20(7): 1434-1441, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967794
11.
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.
Br J Cancer
; 121(3): 264-270, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292535
12.
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
Cancer
; 124(11): 2337-2346, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579325
13.
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer.
Br J Cancer
; 116(8): 1021-1026, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28291774
14.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314841
15.
Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Oncology (Williston Park)
; 31(3): 159-66, 168, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28299752
16.
Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.
Am J Pathol
; 185(5): 1185-97, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747534
17.
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience.
BMC Cancer
; 16: 492, 2016 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430276
18.
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.
Cancer
; 121(10): 1645-53, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641763
19.
Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma.
Oncology (Williston Park)
; 29(11): 809-20, 886, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26573060
20.
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.
Pharmacogenet Genomics
; 24(2): 81-93, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401833